Abstract
Oryzanol is a class of nonsaponifiable lipids of rice bran oil (RBO). More specifically, oryzanol is a group of ferulic acid esters of triterpene alcohol and plant sterols. In experiment 1, the mechanisms of the cholesterol-lowering action of oryzanol were investigated in 32 hamsters made hypercholesterolemic by feeding chow-based diets containing 5% coconut oil and 0.1% cholesterol with or without 1% oryzanol for 7 wk. Relative to the control animals, oryzanol treatment resulted in a significant reduction in plasma total cholesterol (TC) (28%, P<0.01) and the sum of IDL-C, LDL-C, and VLDL-C (NON-HDL-C) (34%, P<0.01). In addition, the oryzanol-treated animals also exhibited a 25% reduction in percent cholesterol absorption vs. control animals. Endogenous cholesterol synthesis, as measured by the liver and intestinal HMG-CoA reductase activities, showed no difference between the two groups. To determine whether a lower dose of oryzanol was also efficacious and to measure aortic fatty streaks, 19 hamsters in experiment 2 were divided into two groups and fed for 10 wk chow-based diets containing 0.05% cholesterol and 10% coconut oil (w/w) (control) and the control diet plus 0.5% oryzanol (oryzanol). Relative to the control, oryzanol-treated hamsters had reduced plasma TC (44%, P<0.001), NON-HDL-C (57%, P<0.01), and triglyceride (TG) (46%, P<0.05) concentrations. Despite a 12% decrease in high density lipoprotein cholesterol (HDL-C) (P<0.01), the oryzanol-treated animals maintained a more optimum NON-HDL-C/HDL-C profile (1.1±0.4) than the contorl (2.5±1.4; P<0.0075). Aortic fatty streak formation, so defined by the degree of accumulation of Oil Red O-stained macrophage-derived foam cells, was reduced 67% (P<0.01) in the oryzanol-treated animals. From these studies, it is concluded that a constituent of the nonsaponifiable lipids of RBO, oryzanol, is at least partially responsible for the cholesterol-lowering action of RBO. In addition, the cholesterol-lowering action of oryzanol was associated with significant reductions in aortic fatty streak formation.
Similar content being viewed by others
Abbreviations
- HDL-C:
-
high density lipoprotein cholesterol
- HMG-CoA reductase:
-
3-hydroxy-3-methylglutaryl CoA reductase
- IDL-C:
-
intermediate density lipoprotein cholesterol
- LDL-C:
-
low density lipoprotein cholesterol
- NON-HDL-C:
-
the sum of IDL-C, LDL-C, and VLDL-C
- PBS:
-
phosphate-buffered saline
- RBO:
-
rice bran oil
- TC:
-
total cholesterol
- TG:
-
triglyceride
- TLC:
-
thin-layer chromatography
- VLDL-C:
-
very low density lipoprotein cholesterol
References
Sharma, R. D., and Rukmini, C. (1986) Rice Bran Oil and Hypocholesterolemia in Rats, Lipids 21, 715–717.
Sharma, R. D., and Rukmini, C. (1987) Hypocholesterolemic Activity of Nonsaponifiable Matter of Rice Bran Oil, Indian J. Med. Res. 85, 278–281.
Srinivasan, M.R., and Satyanarayana, M.N. (1988) Influence of Capsaicin, Eugenol, Curcumin and Ferulic Acid on Sucrose-Induced Hypertriglyceridemia in Rats, Nutr. Rep. Int. 38, 571–581.
Raghuram, T., Brahmaji, C., and Rukmini, C. (1989) Studies on Hypolipidemic Effects of Dietary Rice Bran Oil in Human Subjects, Nutr. Rep. Int. 39(5), 889–895.
Nicolosi, R.J., Ausman, L.M., and Hegsted, D.M. (1991) Rice Bran Oil Lowers Serum Total and Low Density Lipoprotein Cholesterol and Apo B Levels in Nonhuman Primates, Atherosclerosis 88, 133–142.
Lichtenstein, A.H., Ausman, L.M., Carrasco, W., Gualtieri, L.J., Jenner, J.L., Ordovas, J.M., Nicolosi, R.J., Goldin, B.R., and Schaefer, E.J. (1994) Rice Bran Oil Consumption and Plasma Lipid Levels in Moderately Hypercholesterolemic Humans, Arterioscler. Thromb. 14, 549–556.
Rong, N., Ausman, L.M., and Nicolosi, R. (1994) Rice Bran Oil Decreases Plasma LDL Cholesterol by Inhibiting Dietary Cholesterol Absorption. FASEB J 8, A162.
Seetharamaiah, G.S., and Chandrasekhara, N. (1989) Studies on Hypocholesterolemic Activity of Rice Bran Oil, Atherosclerosis 78, 219–223.
Nicolosi, R.J., Rogers, E.J., Ausman, L.M., and Orthoefer, F.T. (1992) Rice Bran Oil and Its Health Benefits, in Rice Science & Technology (Marshall, W., and Wadsworth, J., eds.), Marcel Dekker, Inc., New York.
Reeves III, J.B., and Weihrauch, J.L. (1979) Composition of Foods. Fats and Oils, in Agriculture Handbook No. 8-4, United States Department of Agriculture Science and Education Administration, Washington, D.C.
Sayre, B., and Saunders, R. (1990) Rice Bran and Rice Bran Oil, Lipid Tech. 2(3), 72–76.
Yoshino, G., Kazumi, T., Amano, M., Takeiwa, M., Yamasaki, T., Takashima, S., Iwai, M., Hatanaka, H., and Baba, S. (1989) Effects of γ-Oryzanol on Hyperlipidemic Subjects, Current Therapeutic Res. 45(4), 543–552.
Yoshino, G., Kazumi, T., Amano, M., Takeiwa, M., Yamasaki, T., Takashima, S., Iwai, M., Hatanaka, H., and Baba, S. (1989) Effects of γ-Oryzanol and Probucol on Hyperlipidemia, Current Therapeutic Res. 45(6), 975–982.
Sasaki, J., Takada, Y., Kusuda, M., Tanabe, Y., Matsunaga, A., and Arakawa, K. (1990) Effects of γ-Oryzanol on Serum Lipids and Apolipoproteins in Dyslipidemic Schizophrenics Receiving Major Tranquilizers, Clin. Ther. 12(3), 263–268.
Shinomiya, M., Morisaki, N., Matsuoka, N., Izumi, S., Saito, Y., Kumagai, A., Mitani, K., and Morita, S. (1983) Effects of γ-Oryzanol on Lipid Metabolism in Rats Fed High-Cholesterol Diet, Tohoku J. Exp. Med. 141, 191–197.
Seetharamaiah, G.S., and Chandrasekhara, N. (1988) Hypocholesterolemic Activity of Oryzanol in Rats, Nutr. Rep. Int. 38, 927–935.
Nakamura, H. (1966) Effect of γ-Oryzanol on Hepatic Cholesterol Biosynthesis and Fecal Excretion of Cholesterol Metabolites, Radioisotopes 15, 371–374.
Terpstra, A.H.M., Holmes, J.C., and Nicolosi, R.J. (1991) The Hypocholesterolemic Effect of Dietary Soybean Protein vs. Casein in Hamsters Fed Cholesterol-Free or Cholesterol-Enriched Semipurified Diets, J. Nutr. 121, 944–947.
Krause, B.R., Bousley, R.F., Kieft, K.A., and Stanfield, R.L. (1992) Effect of the ACAT Inhibitor CI-976 on Plasma Cholesterol Concentrations and Distribution in Hamsters Fed Zero- and No-Cholesterol Diets, Clin. Biochem. 25, 371–377.
Allain, C.C., Poon, L.S., Chan, C.S.G., Richmond, W., and Fu, P.C. (1986) Enzymatic Determination of Total Serum Cholesterol, Clin. Chem. 32, 611.
Bucolo, G., and David, H. (1973) Quantitative Determination of Serum Triglycerides by the Use of Enzymes, Clin. Chem. 19, 476.
Kowala, M.C., Nunnari, J.J., Durham, S.K., and Nicolosi, R.J. (1991) Doxazosin and Cholestyramine Similarly Decrease Fatty Streak Formation in the Aortic Arch of Hyperlipidemic Hamsters, Atherosclerosis 91, 35.
Zilversmit, D.B. (1972) A Single Blood Sample Dual Isotope Method for the Measurement of Cholesterol Absorption in Rats, P.S.E.B.M. 140, 862–865.
Zilversmit, D.B., and Hughes, B. (1974) Validation of a Dual-Isotope Plasma Ratio Method for Measurement of Cholesterol Absorption in Rats, J. Lipid Res. 15, 465–473.
Harwood, H.J., Jr., Schneider, M., and Stacpoole, P.W. (1984) Measurement of Human Leukocyte Microsomal HMG-CoA Reductase Activity, J. Lipid Res. 25, 967–978.
Bradford, M.M. (1976) A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Using the Principle of Protein-Dye Binding, Anal. Biochem. 72, 248–254.
Harwood, H.J., Jr., Chandler, C.E., Pellarin, L.D., Bangerter, F.W., Wilkins, R.W., Long, C.A., Gosgrove, P.G., Malinow, M.R., Marzetta, C.A., Pettini, J.L., Savoy, Y.E., and Mayne, J.T. (1993) Pharmacologic Consequences of Cholesterol Absorption Inhibition: Alteration in Cholesterol Metabolism and Reduction in Plasma Cholesterol Concentration Induced by the Synthetic Saponin β-Tigogenin Cellobioside (CP-88818; tiqueside), J. Lipid Res. 34, 377–395.
SAS Institute, Inc. (1985) SAS-STAT Guide for Personal Computer, Version 6 edn., Cary, NC, SAS Institute Incorporated.
Subbian, M., and Ravi, T. (1973) Dietary Plant Sterol: Current Status in Human and Animal Sterol Metabolism, Am. J. Clin. Nutr. 26, 219–225.
Seetharamaiah, G.S., and Prabhakar, J.V. (1986) Oryzanol Content of Indian Rice Bran Oil and Its Extraction from Soap Stock, J. Food Sci. Technol. 23, 270–273.
Tajima, K., Sakamoto, M., Okada, K., Mukai, K., Ishizu, K., Sakurai, H., and Mori, H. (1983) Reaction of Biological Phenolic Antioxidants with Superoxide Generated by Cytochrome P-450 Model System, Biochem. Biophy. Res. Comm. 115(3), 1002–1008.
Graf, E. (1992) Antioxidant Potential of Ferulic Acid, Free Radical Biol. Med. 13(4), 435–448.
Parker, R.A., Sabrah, T., Michael, C., and Gill, B.T. (1995) Relation of Vascular Oxidative Stress, α-Tocopherol, and Hypercholesterolemia to Early Atherosclerosis in Hamsters, Arterioscler. Thromb. Vasc. Biol. 15, 349–358.
Author information
Authors and Affiliations
About this article
Cite this article
Rong, N., Ausman, L.M. & Nicolosi, R.J. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids 32, 303–309 (1997). https://doi.org/10.1007/s11745-997-0037-9
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-997-0037-9